Portfolio company
i2a
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops instruments, software and reagents for microbiology laboratories to automate clinical testing and identify bacterial resistance to antibiotics.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
iFAST
iFAST Diagnostics develops rapid antimicrobial susceptibility testing systems for hospital laboratories to identify effective antibiotics for treating bacterial infections.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
Adjutecpharma
This company develops antibiotic resistance breakers for healthcare providers to treat patients with life-threatening bacterial infections.
MetalloBio
This company develops antimicrobial compounds and medical device coatings to combat antibiotic resistance for the pharmaceutical and healthcare sectors.
Insentio
The company develops artificial intelligence technology for the rapid identification of infectious bacteria to assist healthcare providers and laboratories.
